cyanamide has been researched along with Disease Models, Animal in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashrafian, H; Bøtker, HE; Contractor, H; Cunnington, C; Diesch, J; Jensen, R; Kharbanda, RK; Manlhiot, C; Ormerod, JO; Redington, A; Schmidt, MR; Støttrup, NB | 1 |
| Hori, T; Ishikura, K; Nakamura, R; Tsuji, M; Yamano, Y; Yamawaki, K; Yokoo, K; Yonezawa, S; Yoshida, Y | 1 |
| Barrett, DG; Deaton, DN; Hassell, AM; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Shewchuk, LM; Willard, DH; Wright, LL | 1 |
| Lang, CH; Vary, TC | 1 |
| Guillen, FJ; Vazquez, JJ | 1 |
1 trial(s) available for cyanamide and Disease Models, Animal
| Article | Year |
|---|---|
Aldehyde dehydrogenase-2 inhibition blocks remote preconditioning in experimental and human models.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Analysis of Variance; Animals; Cross-Over Studies; Cyanamide; Disease Models, Animal; Disulfiram; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Forearm; Genotype; Hindlimb; Humans; Ischemic Preconditioning; Linear Models; Mutation; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phenotype; Plethysmography; Rabbits; Regional Blood Flow; Reperfusion Injury; Time Factors; Vasodilation; Vasodilator Agents | 2013 |
4 other study(ies) available for cyanamide and Disease Models, Animal
| Article | Year |
|---|---|
Novel broad-spectrum and long-acting parenteral cephalosporins having an acyl cyanamide moiety at the C-3 terminal: Synthesis and structure-activity relationships.
Topics: Animals; Anti-Infective Agents; Bacteria; Cephalosporins; Cyanamide; Disease Models, Animal; Half-Life; Haplorhini; Male; Mice; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2016 |
Acyclic cyanamide-based inhibitors of cathepsin K.
Topics: Animals; Binding Sites; Bone Resorption; Cathepsin B; Cathepsin H; Cathepsin K; Cathepsin L; Cathepsins; Crystallography, X-Ray; Cyanamide; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Disease Models, Animal; Humans; Hydrogen Bonding; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Osteogenesis; Protein Binding; Rats; Recombinant Proteins; Structure-Activity Relationship | 2005 |
Differential phosphorylation of translation initiation regulators 4EBP1, S6k1, and Erk 1/2 following inhibition of alcohol metabolism in mouse heart.
Topics: Adaptor Proteins, Signal Transducing; Alcohol Dehydrogenase; Animals; Carrier Proteins; Cell Cycle Proteins; Central Nervous System Depressants; Cyanamide; Disease Models, Animal; Enzyme Inhibitors; Ethanol; Eukaryotic Initiation Factors; Fomepizole; Heart; Injections, Intraperitoneal; Mice; Mice, Inbred Strains; Mitogen-Activated Protein Kinase 3; Myocardium; Phosphoproteins; Phosphorylation; Pyrazoles; Ribosomal Protein S6 Kinases, 90-kDa; Specific Pathogen-Free Organisms | 2008 |
Cyanamide-induced liver cell injury. Experimental study in the rat.
Topics: Alcohol Deterrents; Alcohol Drinking; Animals; Body Weight; Cyanamide; Cyanides; Disease Models, Animal; Endoplasmic Reticulum; Glycogen Storage Disease Type IV; Humans; Inclusion Bodies; Liver; Male; Rats; Rats, Inbred Strains | 1984 |